本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

14.60
+0.51003.62%
盘后14.600.00000.00%19:20 EST
成交量:33.40万
成交额:482.07万
市值:4.21亿
市盈率:-3.80
高:14.66
开:14.07
低:13.89
收:14.09
52周最高:15.34
52周最低:4.09
股本:2,886.26万
流通股本:2,083.05万
量比:1.15
换手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-3.8381
每股收益(LYR):-3.8381
净资产收益率:-84.63%
总资产收益率:-16.23%
市净率:6.51
市盈率(LYR):-3.80

数据加载中...

公司资料

公司名字:
Enanta Pharmaceuticals Inc.
交易所:
NASDAQ
成立时间:
1995
员工人数:
120
公司地址:
4 Kingsbury Avenue,Watertown,Massachusetts,United States
邮编:
02472
电话:
传真:
617 607 0530
简介:
Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司,利用强大的、化学驱动的方法和药物发现能力来发现和开发用于病毒学和免疫学适应症的小分子药物。

董事

名称
职位
Bruce L. A. Carter
Director and non-executive Chairman of the Board
Jay R. Luly
President, Director and Chief Executive Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Kristine Peterson
Director
Lesley Russell
Director
Mark G. Foletta
Director
Terry Vance
Director
Yujiro S. Hata
Director

股东

名称
职位
Jay R. Luly
President, Director and Chief Executive Officer
Brendan Luu
Chief Business Officer
Harry R. Trout, III
Vice President, Finance and Interim Principal Financial Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Matthew P. Kowalsky
Chief Legal Officer and Corporate Secretary
Paul J. Mellett
Chief Financial and Administrative Officer
Scott T. Rottinghaus
Chief Medical Officer
Tara L. Kieffer
Chief Product Strategy Officer
Yat Sun Or
Chief Scientific Officer